Skip to main content
. Author manuscript; available in PMC: 2022 Dec 28.
Published in final edited form as: Invest New Drugs. 2022 Oct 20;40(6):1306–1314. doi: 10.1007/s10637-022-01311-w

Table 2.

Disease Site(s) of Involvement

Disease Neuroendocrine Tumor Anatomic Site Involvement N %
Adjacent to kidney 1 2.8
Adjacent Viscera/Vessels 2 5.6
Bone 1 2.8
Liver 12 33.3
Lung 3 8.3
Mediastinum/Hila: More superior node 1 2.8
Periaortic lymph node 1 2.8
Peritoneum 3 8.3
Primary Tumor/Pancreas 8 22.2
Regional Lymph Nodes 4 11.1